^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    Cripto-targeted antibody-drug conjugate

    Related drugs:
    over3years
    A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth. (PubMed, Int J Mol Sci)
    Simultaneously, the antibody exhibited the potential to suppress the growth of human colon cancer derived GEO cells overexpressing Cripto-1 with IC at approximately 110 nM. The artificially humanized antibody is proposed to be a good candidate to target cancer cells overexpressing Cripto-1.
    Journal
    |
    EGF (Epidermal growth factor)